The aim of this study was to determine the seroprevalence of antibodies against Equine Herpes Virus type 1 (EHV-1) and Equine Herpes Virus type 4 (EHV-4), which causes rhinopneumonitis in horses. Blood samples (n=825) from Peruvian horses older than six months of age, both sexes, identified as racehorses, Peruvian Paso, equitation and criollo, in apparent healthy conditions, were collected for detection of neutralizing antibodies against EHV-1/EHV-4 by virus neutralization test. The 48.9 ± 5.3% (403/825) of the samples had antibodies against EHV-1/EHV-4. Antibody titers ranged from 2 to >256, where 58.5% ranged from 2 to 8, 29.5% from 16 to 64, and 11.9% from 128 to >256. The sex and region of the country did not represent a risk for presenting antibodies against EHV-1/EHV-4.

The aim of this study was to determine the seroprevalence of antibodies against Equine Herpes Virus type 1 (EHV-1) and Equine Herpes Virus type 4 (EHV-4), which causes rhinopneumonitis in horses. Blood samples (n=825) from Peruvian horses older than six months of age, both sexes, identified as racehorses, Peruvian Paso, equitation and criollo, in apparent healthy conditions, were collected for detection of neutralizing antibodies against EHV-1/EHV-4 by virus neutralization test. The 48.9 ± 5.3% (403/825) of the samples had antibodies against EHV-1/EHV-4. Antibody titers ranged from 2 to >256, where 58.5% ranged from 2 to 8, 29.5% from 16 to 64, and 11.9% from 128 to >256. The sex and region of the country did not represent a risk for presenting antibodies against EHV-1/EHV-4.

Introducción: El VIH sigue siendo un problema prioritario en los sistemas de salud a nivel mundial, el desarrollo del tratamiento antirretroviral (TAR) ha constituido uno de los mayores retos en la lucha contra la epidemia del VIH/SIDA. Es importante identificar los factores que estén relacionados con un fallo en la adherencia al tratamiento antirretroviral, para poder tener indicadores que alerten sobre el fracaso terapéutico. Objetivo: Identificar los factores de riesgo asociados a la mala adherencia a la terapia antirretroviral en personas que viven con VIH del Hospital Sergio Bernales en el periodo 2019 – 2021. Métodos: Estudio observacional, analítico, retrospectivo de casos y controles. La población está constituida por 276 pacientes, divididos en dos grupos casos y controles en relación de 1:1. Se utilizó una ficha de recolección de datos en la que se registraron todos...